Scientists probe lung microbiome to unlock COPD secrets
NCT ID NCT02777879
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at the bacteria living in the lungs of smokers with and without early-stage COPD. Researchers will use a bronchoscopy to collect samples and analyze how these bacteria and the body's immune response differ between the two groups. The goal is to better understand what drives COPD in its early stages, which could lead to new ways to detect or treat the disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could reveal how lung bacteria contribute to COPD, pointing toward future treatments or prevention strategies.
- What could go wrong
- This is an observational study, not a treatment trial. It may not lead directly to new therapies, and findings may not apply to all COPD patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC OBSTUCTIVE PULMONARY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
New York University School of Medicine
RECRUITINGNew York, New York, 10016, United States